Evidence map›Paper›PMID 30477537›Full record

ArticleJournal of experimental & clinical cancer research : CR2018

Distinct expression profiles and functions of Kindlins in breast cancer.

Paula Azorin, Florian Bonin, Ahmad Moukachar, Aurélie Ponceau, Sophie Vacher, Ivan Bièche, Elisabetta Marangoni, Laetitia Fuhrmann, Anne Vincent-Salomon, Rosette Lidereau and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of experimental & clinical cancer research : CR, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Kindlin-1 drives early steps of breast cancer metastasis.Cancer communications (London, England) · 2022
    Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Kindlins as modulators of breast cancer progression.Journal of breast cancer research · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Paula AzorinPharmacogenomics Unit, Genetics Department, Institut Curie, 26 rue d'Ulm, 75248, Paris cedex 05, France. paula.azorinpardo@curie.fr.ORCID http://orcid.org/0000-0002-6925-2244
Florian BoninPharmacogenomics Unit, Genetics Department, Institut Curie, 26 rue d'Ulm, 75248, Paris cedex 05, France.
Ahmad MoukacharPharmacogenomics Unit, Genetics Department, Institut Curie, 26 rue d'Ulm, 75248, Paris cedex 05, France.
Aurélie PonceauPharmacogenomics Unit, Genetics Department, Institut Curie, 26 rue d'Ulm, 75248, Paris cedex 05, France.
Sophie VacherPharmacogenomics Unit, Genetics Department, Institut Curie, 26 rue d'Ulm, 75248, Paris cedex 05, France.
Ivan BièchePharmacogenomics Unit, Genetics Department, Institut Curie, 26 rue d'Ulm, 75248, Paris cedex 05, France.
Elisabetta MarangoniTranslational Research Department, Institut Curie, PSL Research University, Paris, France.
Laetitia FuhrmannPathology Department, Institut Curie, Paris, France.
Anne Vincent-SalomonPathology Department, Institut Curie, Paris, France.
Rosette LidereauPharmacogenomics Unit, Genetics Department, Institut Curie, 26 rue d'Ulm, 75248, Paris cedex 05, France.
Keltouma DriouchPharmacogenomics Unit, Genetics Department, Institut Curie, 26 rue d'Ulm, 75248, Paris cedex 05, France.
Institut Curie · FRUniversité Paris Sciences et Lettres · FR

Funding

Breast Cancer Research Foundation BCRF-16-096INCA/Cancéropole Ile-de-France 2012-1-PL BIO-05-IC-1
6 · The paper itself

Abstract

backgroundKindlin-1, - 2, and - 3 are the three members of the Kindlin family. They are best known as regulators of integrin functions, contributing to fundamental biological processes such as cell survival, adhesion and migration. Their deregulation leads to diverse pathologies including a broad range of cancers in which both, tumor-promoting and tumor-inhibiting functions have been described.

methodsTo better characterize Kindlins implication in breast cancer, in vitro experiments were performed in a series of cancer cell lines. We first assessed their expression profiles and subcellular distributions. Then, their involvement in breast cancer cell morphology, migration and invasion was verified by examining phenotypic changes induced by the depletion of either isoforms using RNA interference. An expression study was performed in a series of breast cancer patient derived xenografts (n = 58) to define the epithelial and stromal contribution of each Kindlin. Finally, we analyzed the expression levels of the three Kindlins in a large series of human breast tumors, at the RNA (n = 438) and protein (n = 129) levels and we evaluated their correlation with the clinical outcome.

resultsWe determined that Kindlin-1 and Kindlin-2, but not Kindlin-3, were expressed in breast tumor cells. We uncovered the compensatory roles of Kindlin-1 and -2 in focal adhesion dynamics and cell motility. Remarkably, Kindlin-2 had a predominant effect on cell spreading and Kindlin-1 on cell invasion. In line with these experimental observations, Kindlin-1 overexpression was associated with a worse patients' outcome. Notably, Kindlin-3, expressed by tumor infiltrating leukocytes, also correlated with a poor prognosis of breast cancer patients.

conclusionThis study demonstrates that each one of the Kindlin family members has a different expression profile emphasizing their redundant and complementary roles in breast tumor cells. We highlight the specific link between Kindlin-1 and breast cancer progression. In addition, Kindlin-3 overexpression in the tumor microenvironment is associated with more aggressive breast tumors. These results suggest that Kindlins play distinctive roles in breast cancer. Kindlins may be useful in identifying breast cancer patients with a worst prognosis and may offer new avenues for therapeutic intervention against cancer progression.

Indexed as

Breast NeoplasmsCell Line, TumorFemaleHumansImmunohistochemistryLymphocytes, Tumor-InfiltratingMCF-7 CellsMembrane ProteinsNeoplasm ProteinsPrognosisTransfectionFERMT1 protein, humanFERMT3 protein, humanMembrane ProteinsNeoplasm ProteinsBreast cancerInvasionKindlinsPrognosisRedundant functions

Identifiers

PMID30477537
PMCPMC6260766
OpenAlexW2902857005

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.